Fluor Varnish With Silver Nanoparticles for Dental Remineralization in Patients With Trisomy 21
Primary Purpose
Down Syndrome
Status
Unknown status
Phase
Phase 2
Locations
Mexico
Study Type
Interventional
Intervention
Fluor varnish
Fluor varnish with nanoparticles
Sponsored by
About this trial
This is an interventional prevention trial for Down Syndrome focused on measuring Down syndrome, Caries, Dental varnish
Eligibility Criteria
Inclusion Criteria:
- Patients with trisomy 21 diagnosed through caryotype
- Age 1 to 6 years old
- Any sex
- White spot present in both upper anterior teeth
- Parental agreement to participate in the study
Exclusion Criteria:
- Hypersensibility to any of the substances used
- Non cooperating patients
- Caries in enamel or dentine in the upper anterior teeth
- Leukemia or diabetes
- Dental fluorosis present
Sites / Locations
- Universidad Autónoma de San Luis Potosí
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Experimental
Arm Label
Fluor varnish
Fluor varnish with nanoparticles
Arm Description
Fluor dental varnish (Fluor Protector, Ivoclar Vivadent, Principality of Liechtenstein)
Fluor dental varnish (Fluor Protector, Ivoclar Vivadent, Principality of Liechtenstein) plus 25% 50 nm silver nanoparticles.
Outcomes
Primary Outcome Measures
Remineralization
Remineralization status will be assessed through laser fluorescence of the tooth with a Diagnodent probe (Diagnodent, Kavo, Madrid, Spain)
Secondary Outcome Measures
Full Information
NCT ID
NCT01975545
First Posted
September 3, 2013
Last Updated
March 5, 2014
Sponsor
Universidad Autonoma de San Luis Potosí
1. Study Identification
Unique Protocol Identification Number
NCT01975545
Brief Title
Fluor Varnish With Silver Nanoparticles for Dental Remineralization in Patients With Trisomy 21
Official Title
Efficacy of the Addition of Silver Nanoparticles to a Fluor Varnish in the Remineralization of Temporary Teeth in Patients With Trisomy 21. Randomized Clinical Trial.
Study Type
Interventional
2. Study Status
Record Verification Date
March 2014
Overall Recruitment Status
Unknown status
Study Start Date
September 2012 (undefined)
Primary Completion Date
April 2014 (Anticipated)
Study Completion Date
May 2014 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Universidad Autonoma de San Luis Potosí
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Patients with trisomy 21 are in greater danger of developing caries. It has been hypothesized that adding silver nanoparticles to fluor varnishes could promote remineralization of the teeth. A split-plot randomized controlled trial will be performed to address this question.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Down Syndrome
Keywords
Down syndrome, Caries, Dental varnish
7. Study Design
Primary Purpose
Prevention
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigator
Allocation
Randomized
Enrollment
20 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Fluor varnish
Arm Type
Active Comparator
Arm Description
Fluor dental varnish (Fluor Protector, Ivoclar Vivadent, Principality of Liechtenstein)
Arm Title
Fluor varnish with nanoparticles
Arm Type
Experimental
Arm Description
Fluor dental varnish (Fluor Protector, Ivoclar Vivadent, Principality of Liechtenstein) plus 25% 50 nm silver nanoparticles.
Intervention Type
Drug
Intervention Name(s)
Fluor varnish
Other Intervention Name(s)
Fluor dental varnish
Intervention Description
Dental varnish will be applied to one anterior superior teeth in a random side.
Intervention Type
Drug
Intervention Name(s)
Fluor varnish with nanoparticles
Other Intervention Name(s)
Fluor dental varnish with silver nanoparticles.
Intervention Description
Dental varnish with silver nanoparticles will be applied to one anterior superior teeth in a random side.
Primary Outcome Measure Information:
Title
Remineralization
Description
Remineralization status will be assessed through laser fluorescence of the tooth with a Diagnodent probe (Diagnodent, Kavo, Madrid, Spain)
Time Frame
3 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
1 Year
Maximum Age & Unit of Time
6 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients with trisomy 21 diagnosed through caryotype
Age 1 to 6 years old
Any sex
White spot present in both upper anterior teeth
Parental agreement to participate in the study
Exclusion Criteria:
Hypersensibility to any of the substances used
Non cooperating patients
Caries in enamel or dentine in the upper anterior teeth
Leukemia or diabetes
Dental fluorosis present
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Mauricio Pierdant-Pérez, Md, MSc
Organizational Affiliation
Universidad Autónoma de San Luis Potosí
Official's Role
Study Director
Facility Information:
Facility Name
Universidad Autónoma de San Luis Potosí
City
San Luis Potosí
ZIP/Postal Code
78210
Country
Mexico
12. IPD Sharing Statement
Learn more about this trial
Fluor Varnish With Silver Nanoparticles for Dental Remineralization in Patients With Trisomy 21
We'll reach out to this number within 24 hrs